Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
BelgiumStudy on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma
The NetherlandsStudy on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis
DenmarkStudy of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer
CzechiaStudy on Reducing Side Effects of Lutetium (177Lu) Oxodotreotide in Patients with Advanced Midgut Neuroendocrine Tumors
FranceStudy Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations
BelgiumStudy Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients
FranceStudy on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis
The NetherlandsStudy on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer
BelgiumStudy on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease
The NetherlandsStudy to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors
FranceTitle: Study of vedolizumab dose adjustment guided by drug level monitoring in patients with inflammatory bowel disease in remission
The NetherlandsThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
